TY  - JOUR
AU  - Bover Sanjuan, Jordi
AU  - Navarro-Gonzalez, Juan Francisco
AU  - Arenas, M Dolores
AU  - Torregrosa, Jose-Vicente
AU  - Tamargo Menendez, Juan
AU  - de Francisco, Angel Luis Martin
AU  - Gonzalez-Parra, Emilio
AU  - Lloret Cora, M Jesus
AU  - Sanchez Alvarez, J Emilio
AU  - Martin-Malo, Alejandro
AU  - Molina Vila, Pablo
AU  - Bajo, M Auxiliadora
AU  - DaSilva Santos, Iara
PY  - 2018
DO  - 10.1016/j.nefro.2018.05.003
UR  - http://hdl.handle.net/10668/13229
T2  - Nefrologia
AB  - The use of phosphate binders is one of basic elements in the treatment of CKD-MBD (“Chronic Kidney Disease-Mineral and Bone Disorder”). It has been well known for decades that phosphate reten tion through direct and indirect mechanisms, contributes to...
LA  - en
PB  - Elsevier
KW  - Phosphates
KW  - Fibroblast growth factor-23
KW  - Aging, premature
KW  - Electronic mail
KW  - Renal insufficiency, chronic
KW  - Chelating agents
KW  - Drug interactions
KW  - Humans
KW  - Phosphates
KW  - Renal insufficiency, chronic
KW  - Chronic kidney disease-mineral and bone disorder
TI  - Pharmacological interactions of phosphate binders.
T2  - Interacciones farmacológicas de los captores del fósforo.
TY  - research article
VL  - 38
ER  -